Arno Therapeutics, Inc.
ARNI · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Market Cap | $21 | $13 | $15 | $7 |
| - Cash | $2 | $1 | $3 | $0 |
| + Debt | $0 | $0 | $0 | $2 |
| Enterprise Value | $19 | $12 | $12 | $9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4 | -$2 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$2 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.086 | -0.052 | -0.096 | -0.2 |
| % Growth | -66.9% | 46.3% | 52% | – |
| Operating Cash Flow | -$1 | -$2 | -$3 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$2 | -$3 | -$2 |